TRV-AAC1-2 (tRNA-Val (anticodon AAC) 1-2) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: TRV-AAC1-2 (tRNA-Val (anticodon AAC) 1-2) Homo sapiens
Analyze
Symbol: TRV-AAC1-2
Name: tRNA-Val (anticodon AAC) 1-2
RGD ID: 2300987
HGNC Page HGNC:34542
Description:
Type: trna
RefSeq Status: MODEL
Previously known as: transfer RNA-Val (AAC) 1-2; TRNAV5
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh385181,164,154 - 181,164,226 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh375180,591,154 - 180,591,226 (+)NCBIGRCh37GRCh37hg19GRCh37
Cytogenetic Map5q35.3NCBI
HuRef5175,318,564 - 175,318,636 (+)NCBIHuRef
CHM1_15180,022,101 - 180,022,173 (+)NCBICHM1_1
T2T-CHM13v2.05181,724,177 - 181,724,249 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


References
Additional References at PubMed
PMID:18984615  


Genomics


Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 5q33.3-35.3(chr5:156825512-181269805)x3 copy number gain See cases [RCV000133847] Chr5:156825512..181269805 [GRCh38]
Chr5:156252523..180696806 [GRCh37]
Chr5:156185101..180629412 [NCBI36]
Chr5:5q33.3-35.3
pathogenic
GRCh38/hg38 5q35.3(chr5:181149812-181177344)x3 copy number gain See cases [RCV000134764] Chr5:181149812..181177344 [GRCh38]
Chr5:180576812..180604344 [GRCh37]
Chr5:180509418..180536950 [NCBI36]
Chr5:5q35.3
benign|likely benign|conflicting data from submitters
GRCh38/hg38 5q34-35.3(chr5:164386701-181269805)x3 copy number gain See cases [RCV000135546] Chr5:164386701..181269805 [GRCh38]
Chr5:163813707..180696806 [GRCh37]
Chr5:163746285..180629412 [NCBI36]
Chr5:5q34-35.3
pathogenic
GRCh38/hg38 5q35.3(chr5:180636182-181269805)x3 copy number gain See cases [RCV000136903] Chr5:180636182..181269805 [GRCh38]
Chr5:180063182..180696806 [GRCh37]
Chr5:179995788..180629412 [NCBI36]
Chr5:5q35.3
uncertain significance
GRCh38/hg38 5q35.1-35.3(chr5:169334755-181285301)x3 copy number gain See cases [RCV000141249] Chr5:169334755..181285301 [GRCh38]
Chr5:168761759..180712302 [GRCh37]
Chr5:168694337..180644908 [NCBI36]
Chr5:5q35.1-35.3
pathogenic
GRCh38/hg38 5q35.2-35.3(chr5:175536771-181292788)x1 copy number loss See cases [RCV000141987] Chr5:175536771..181292788 [GRCh38]
Chr5:174963774..180719789 [GRCh37]
Chr5:174896380..180652395 [NCBI36]
Chr5:5q35.2-35.3
pathogenic
GRCh38/hg38 5q35.3(chr5:181125345-181238978)x3 copy number gain See cases [RCV000141545] Chr5:181125345..181238978 [GRCh38]
Chr5:180552345..180665978 [GRCh37]
Chr5:180484951..180598584 [NCBI36]
Chr5:5q35.3
uncertain significance
GRCh38/hg38 5q35.3(chr5:178235909-181292788)x3 copy number gain See cases [RCV000142298] Chr5:178235909..181292788 [GRCh38]
Chr5:177662910..180719789 [GRCh37]
Chr5:177595516..180652395 [NCBI36]
Chr5:5q35.3
likely pathogenic
GRCh38/hg38 5q35.2-35.3(chr5:176700128-181269805)x1 copy number loss See cases [RCV000142648] Chr5:176700128..181269805 [GRCh38]
Chr5:176127129..180696806 [GRCh37]
Chr5:176059735..180629412 [NCBI36]
Chr5:5q35.2-35.3
pathogenic
GRCh38/hg38 5q35.3(chr5:178529878-181269805)x3 copy number gain See cases [RCV000051205] Chr5:178529878..181269805 [GRCh38]
Chr5:177956879..180696806 [GRCh37]
Chr5:177889485..180629412 [NCBI36]
Chr5:5q35.3
uncertain significance
GRCh38/hg38 5q32-35.3(chr5:149714592-181272151)x3 copy number gain See cases [RCV000051863] Chr5:149714592..181272151 [GRCh38]
Chr5:149094155..180699152 [GRCh37]
Chr5:149074348..180631758 [NCBI36]
Chr5:5q32-35.3
pathogenic
GRCh38/hg38 5q33.3-35.3(chr5:160029980-181269805)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051865]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051865]|See cases [RCV000051865] Chr5:160029980..181269805 [GRCh38]
Chr5:159456987..180696806 [GRCh37]
Chr5:159389565..180629412 [NCBI36]
Chr5:5q33.3-35.3
pathogenic
GRCh38/hg38 5q34-35.3(chr5:168689326-181269946)x3 copy number gain See cases [RCV000051866] Chr5:168689326..181269946 [GRCh38]
Chr5:168116331..180696947 [GRCh37]
Chr5:168048909..180629553 [NCBI36]
Chr5:5q34-35.3
pathogenic
Markers in Region
116XA3  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh375180,589,794 - 180,590,014UniSTSGRCh37
Build 365180,522,400 - 180,522,620RGDNCBI36
Celera5176,217,203 - 176,217,417RGD
Cytogenetic Map6p22.1UniSTS
HuRef5175,317,210 - 175,317,424UniSTS


Expression


Sequence



Additional Information

Database Acc Id Source(s)
COSMIC TRV-AAC1-2 COSMIC
GTEx TRV-AAC1-2 GTEx
HGNC ID HGNC:34542 ENTREZGENE
Human Proteome Map TRV-AAC1-2 Human Proteome Map
NCBI Gene 100188990 ENTREZGENE


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2019-05-07 TRV-AAC1-2  tRNA-Val (anticodon AAC) 1-2  TRV-AAC1-2  transfer RNA-Val (AAC) 1-2  Symbol and/or name change 5135510 APPROVED
2014-06-24 TRV-AAC1-2  transfer RNA-Val (AAC) 1-2  TRNAV5  transfer RNA valine 5 (anticodon AAC)  Symbol and/or name change 5135510 APPROVED